This compound is primarily used as an intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring a pyrrolidine ring and a protected amine group, makes it valuable in the development of drugs targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease. It is also employed in the creation of chiral molecules, where its stereochemistry plays a crucial role in enhancing the efficacy and selectivity of therapeutic compounds. Additionally, it finds application in the production of small molecule inhibitors and modulators for biological targets, contributing to advancements in medicinal chemistry and drug discovery.